Cancer / Immunology
Thermo Fisher & Boehringer Ingelheim Join Forces for NSCLC Companion Diagnostics in Japan and the US
To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targete...
October 20, 2023 | News
SOPHiA GENETICS Partners with MSKCC and AstraZeneca for Global Cancer Care Equality
SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with&...
October 19, 2023 | News
Nona Biosciences and INGENIA Therapeutics Join Forces for Immunology Breakthroughs
By harnessing the immense expertise and resources of both companies, the collaboration aims to accelerate the development of innovative therapeutics for im...
October 16, 2023 | News
Specialised Therapeutics Secures Exclusive License for Novel Ovarian Cancer Treatment from CanariaBio
First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progress...
October 13, 2023 | News
CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...
October 13, 2023 | News
MediLink and BioNTech Partner for Advanced Anti-Cancer Drug
Under the terms of the agreement, MediLink will grant BioNTech exclusive global rights for the development, manufacturing, and commercialization of one of ...
October 13, 2023 | News
CanariaBio and Hikma Sign Oregovomab Distribution and License Deal for MENA Region
"We are thrilled to partner with Hikma, a company with a strong presence in the MENA region and a proven track record of successful collaborations," said&n...
October 11, 2023 | News
Thermo Fisher Scientific Expands St. Louis Manufacturing for Complex Biologic Treatments
Thermo Fisher Scientific, the world leader in serving science, expanded its manufacturing capacity in St. Louis to support biologic therapies for dis...
October 06, 2023 | News
RevitaLash® Launches Global Initiative to Fight Breast Cancer
RevitaLash® Cosmetics is proud to announce the company's annual Pink mission to make an impact in the fight against breast cancer. This initiative...
October 04, 2023 | News
Australia's First Cu-67 SAR-Bombesin Prostate Cancer Trial Patient Treated
COMBAT, which derives from "Copper-67 SAR-Bombesin in metastatic castrate resistant prostate cancer (NCT05633160)1 is a dose escalation and co...
October 04, 2023 | News
FDA Clears Transcenta for Global Phase III Trial of Osemitamab in Gastric Cancer
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...
October 04, 2023 | News
Akeso and RemeGen Team Up for Gastric Cancer Therapy Study
On September 28, 2023, Akeso (9926.HK) announced that its subsidiary, Akeso Pharma, will collaborate with RemeGen (Yantai) Co., Ltd. (688331.SH/0...
October 02, 2023 | News
Mabwell Starts Phase Ib/II Trial for Nectin-4 ADC with PD-1 Inhibitor
The clinical trial (CTR20232677) is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetic profile of 9MW2821 in combination with ...
September 29, 2023 | News
Advanced Cancer Imaging Tool Streamlines Radiotherapy Adjustment for Doctors
An innovative technology that captures high-quality images of a tumor in six seconds is being used to guide cancer treatments for patients receiving care a...
September 29, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
